Mitsubishi Chemical Group Corporation

10/18/2023 | Press release | Distributed by Public on 10/17/2023 20:03

MT-2111 in Phase 2 part of Phase 1/2 Clinical Trial in Diffuse Large B-cell Lymphoma in JapanNEW